CONCLUSION:The efficacy of Anzatax in treatment of advanced breast and ovary cancer are confirmed and its effect in treatment of NSCLC need to be further observed.

• 不良反应主要为消化道反应、肌肉痛、乏力、脱发和骨髓抑制。结论：安素泰对晚期卵巢癌、乳腺癌疗效肯定，对NSCLC的疗效有待进一步确定。